Disparities in Acceptance of Deceased Donor Kidneys Between the United States and France and Estimated Effects of Increased US Acceptance.


Journal

JAMA internal medicine
ISSN: 2168-6114
Titre abrégé: JAMA Intern Med
Pays: United States
ID NLM: 101589534

Informations de publication

Date de publication:
01 Oct 2019
Historique:
pubmed: 27 8 2019
medline: 27 8 2019
entrez: 27 8 2019
Statut: ppublish

Résumé

Approximately 3500 donated kidneys are discarded in the United States each year, drawing concern from Medicare and advocacy groups. To estimate the effects of more aggressive allograft acceptance practices on the donor pool and allograft survival for the population of US wait-listed kidney transplant candidates. A nationwide study using validated registries from the United States and France comprising comprehensive cohorts of deceased donors with organs offered to kidney transplant centers between January 1, 2004, and December 31, 2014. Data were analyzed between September 1, 2018, and April 5, 2019. The primary outcome was kidney allograft discard. The secondary outcome was allograft failure after transplantation. We used logistic regression to model organ acceptance and discard practices in both countries. We then quantified using computer simulation models the number of kidneys discarded in the United States that a more aggressive system would have instead used for transplantation. Finally, based on actual survival data, we quantified the additional years of allograft life that a redesigned US system would have saved. In the United States, 156 089 kidneys were recovered from deceased donors between 2004 and 2014, of which 128 102 were transplanted, and 27 987 (17.9%) were discarded. In France, among the 29 984 kidneys recovered between 2004 and 2014, 27 252 were transplanted, and 2732 (9.1%, P < .001 vs United States) were discarded. The mean (SD) age of kidneys transplanted in the United States was 36.51 (17.02) years vs 50.91 (17.34) years in France (P < .001). Kidney quality showed little change in the United States over time (mean [SD] kidney donor risk index [KDRI], 1.30 [0.48] in 2004 vs 1.32 [0.46] in 2014), whereas a steadily rising KDRI in France reflected a temporal trend of more aggressive organ use (mean [SD] KDRI, 1.37 [0.47] in 2004 vs 1.74 [0.72] in 2014; P < .001). We applied the French-based allocation model to the population of US deceased donor kidneys and found that 17 435 (62%) of kidneys discarded in the United States would have instead been transplanted under the French system. We further determined that a redesigned system with more aggressive organ acceptance practices would generate an additional 132 445 allograft life-years in the United States over the 10-year observation period. Greater acceptance of kidneys from deceased donors who are older and have more comorbidities could provide major survival benefits to the population of US wait-listed patients. ClinicalTrials.gov identifier: NCT03723668.

Identifiants

pubmed: 31449299
pii: 2748452
doi: 10.1001/jamainternmed.2019.2322
pmc: PMC6714020
doi:

Banques de données

ClinicalTrials.gov
['NCT03723668']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1365-1374

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Olivier Aubert (O)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Peter P Reese (PP)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Medicine, Renal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia.
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Benoit Audry (B)

Agence de la Biomédecine, Saint Denis la Plaine, France.

Yassine Bouatou (Y)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Marc Raynaud (M)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.

Denis Viglietti (D)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Christophe Legendre (C)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Denis Glotz (D)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Jean-Phillipe Empana (JP)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.

Xavier Jouven (X)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.

Carmen Lefaucheur (C)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Christian Jacquelinet (C)

Agence de la Biomédecine, Saint Denis la Plaine, France.
INSERM U1018, CESP, Université Paris Sud, Villejuif, France.

Alexandre Loupy (A)

Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France.
Department of Kidney Transplantation, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Classifications MeSH